ロード中...
nab-Paclitaxel for the treatment of pancreatic cancer
BACKGROUND: Nanoparticle albumin-bound paclitaxel (nab-P) plus gemcitabine (Gem) became a standard treatment option for metastatic pancreatic cancer (MPC) following positive results from a global phase III trial (MPACT). A large number of studies have now published results on the use of nab-P/Gem to...
保存先:
| 出版年: | Cancer Manag Res |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5360414/ https://ncbi.nlm.nih.gov/pubmed/28356771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S127840 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|